Literature DB >> 1969887

Subcutaneous infusions for control of cancer symptoms.

P Storey, H H Hill, R H St Louis, E E Tarver.   

Abstract

Continuous subcutaneous infusions offer a safe, simple, effective alternative to intravenous or intramuscular injections when oral medications cannot be used. They are extremely useful for cancer patients suffering from pain, vomiting, seizures, and other symptoms. Hydromorphone or morphine may be combined with metoclopramide, methotrimeprazine, or haloperidol (in D5W only), in the same pump to control both pain and nausea. Seizures can be controlled by subcutaneous infusion of phenobarbital or midazolam. If proper doses are prescribed and skin irritation is watched for, they can be used safely in the patient's home.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969887     DOI: 10.1016/s0885-3924(05)80007-7

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  16 in total

Review 1.  Practical guide to palliative sedation.

Authors:  John D Cowan; Teresa W Palmer
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

Review 2.  Pain management in the home.

Authors:  Nessa Coyle
Journal:  Curr Pain Headache Rep       Date:  2005-08

3.  Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide.

Authors:  Emilia Barcia; Rodrigo Reyes; Maria Luz Azuara; Yolanda Sánchez; Sofía Negro
Journal:  Support Care Cancer       Date:  2004-11-18       Impact factor: 3.603

4.  Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspnea.

Authors:  N MacDonald
Journal:  West J Med       Date:  1995-09

Review 5.  Opioid analgesics: comparative features and prescribing guidelines.

Authors:  N I Cherny
Journal:  Drugs       Date:  1996-05       Impact factor: 9.546

6.  An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain.

Authors:  Magdi Hanna; Alberto Tuca; John Thipphawong
Journal:  BMC Palliat Care       Date:  2009-09-15       Impact factor: 3.234

7.  Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump?

Authors:  Sasson Menahem; Pesach Shvartzman
Journal:  Support Care Cancer       Date:  2009-09-30       Impact factor: 3.603

8.  [Continuous subcutaneous application of analgesics in a patient suffering from a head and neck tumor.].

Authors:  I Gralow; W von Hornstein
Journal:  Schmerz       Date:  1992-12       Impact factor: 1.107

9.  [Pharmacotherapy of cancer pain : 2. Use of opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-01       Impact factor: 1.107

10.  [Patient-controlled analgesia in outpatients with severe cancer pain.].

Authors:  M Herbst; H Goeke
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.